Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Scholarship programme for the innovators of the future launched

The Ellison Scholars programme, announced by the Ellison Institute of Technology (EIT), will find and fund students and train them to become leaders with the skills to invent, improve, and manage the next generation of technology, to help solve some of humanity’s most challenging and enduring problems.

Group of eight students women and men in a laboratory discissing

This student scholarship programme will recruit approximately twenty students from around the world each year, providing a full scholarship for study at the University of Oxford. Together, they will collaborate on projects in EIT’s four areas of humane endeavours: medical science and healthcare; food security and sustainable agriculture; clean energy and climate change; and government policy and economics. This programme will expedite the Scholars’ journeys to becoming global technology innovators and leaders of the future.

Scholars will also receive mentorship from world leaders, scientist and entrepreneurs in the EIT Faculty of Fellows, led by Dr David Agus, Founding Director & CEO of EIT and Visiting Professor of Medicine at the University of Oxford; Professor Sir John Bell, Regius Professor of Medicine at the University of Oxford; and Sir Tony Blair, Executive Chairman of the Tony Blair Institute for Global Change (TBI).

 

Read the full story on the University of Oxford's website.

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.